AI English summary of an SEC filing — figures as filed

The company said on Friday, October 1, 2025, its subsidiaries OCH and ERH entered into a purchase agreement with Berkshire Hathaway. Berkshire Hathaway agreed to acquire all of the equity in Occidental Chemical Corporation, which holds the chemical business (OxyChem), for $9.7 billion in an all-cash deal.

8-KEntry into a Material Definitive AgreementFiled Oct 3, 2025Period of report Oct 1, 2025Summary published (UTC) Oct 12, 2026

Key points

AI summary

The company said on Friday, October 1, 2025, its subsidiaries OCH and ERH entered into a purchase agreement with Berkshire Hathaway. Berkshire Hathaway agreed to acquire all of the equity in Occidental Chemical Corporation, which holds the chemical business (OxyChem), for $9.7 billion in an all-cash deal.
Occidental said the purchase price is subject to customary adjustments for cash and debt, and for working capital changes against an agreed working capital target. It described OxyChem as a global manufacturer of commodity chemicals used in water treatment, pharmaceuticals, healthcare, and commercial and residential development. The purchase price is $9.7 billion.
The company said closing is subject to the expiration or early termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period and other required regulatory approvals. The agreement can be terminated if closing has not occurred by March 30, 2026, but the deadline is automatically extended by 90 days if regulatory approval conditions have not been met.
The company said OCH has indemnity obligations to Berkshire Hathaway for OxyChem pre-closing liabilities and related matters. ERH will retain environmental liabilities for OxyChem's legacy sites and has also agreed to indemnify Berkshire Hathaway for those liabilities. At closing, Occidental plans to provide Berkshire Hathaway with a guaranty of these indemnification obligations.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Occidental agrees to sell all OxyChem equity to Berkshire Hathaway for $9.7 billion

The company said on Friday, October 1, 2025, its subsidiaries OCH and ERH entered into a purchase agreement with Berkshire Hathaway. Berkshire Hathaway agreed to acquire all of the equity in Occidental Chemical Corporation, which holds the chemical business (OxyChem), for $9.7 billion in an all-cash deal.

Source · Based on the filing body and exhibits

Purchase price subject to adjustments for cash, debt and working capital

Occidental said the purchase price is subject to customary adjustments for cash and debt, and for working capital changes against an agreed working capital target. It described OxyChem as a global manufacturer of commodity chemicals used in water treatment, pharmaceuticals, healthcare, and commercial and residential development. The purchase price is $9.7 billion.

Source · Based on the filing body and exhibits

Closing conditions and termination deadline

The company said closing is subject to the expiration or early termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period and other required regulatory approvals. The agreement can be terminated if closing has not occurred by March 30, 2026, but the deadline is automatically extended by 90 days if regulatory approval conditions have not been met.

Source · Based on the filing body and exhibits

Indemnity scope, retained environmental liabilities and closing agreements

The company said OCH has indemnity obligations to Berkshire Hathaway for OxyChem pre-closing liabilities and related matters. ERH will retain environmental liabilities for OxyChem's legacy sites and has also agreed to indemnify Berkshire Hathaway for those liabilities. At closing, Occidental plans to provide Berkshire Hathaway with a guaranty of these indemnification obligations.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.